Stromelysin-3: A potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma

Matthias Thewes, W. I. Worret, R. Engst, J. Ring

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Histopathological differentiation between desmoplastic trichoepithelioma (DTE) and morphealike basal cell carcinoma (BCC) is a difficult problem because of their similar morphological features. The matrix metalloproteinase stromelysin-3 (ST-3), which is expressed as a specific fibroblastic factor especially surrounding carcinoma cells, was studied in these both conditions of wholly different clinical outcome. Using formalin-fixed paraffin-embedded tissues, we found positive immunoreactivity for ST-3 in fibroblastic cells surrounding morphealike BCC cells in 34 (68%) of 50 cases, whereas the epithelial tumor cells themselves were negative. In none of the 12 cases of DTE did we observe expression of ST-3 in fibroblasts. We conclude that the antibody against ST-3 protein is an immunohistochemical marker to distinguish morphealike BCC from DTE.

Original languageEnglish
Pages (from-to)140-142
Number of pages3
JournalAmerican Journal of Dermatopathology
Volume20
Issue number2
DOIs
StatePublished - 1998
Externally publishedYes

Keywords

  • Desmoplastic trichoepithelioma
  • Immunohistochemistry
  • Matrix metalloproteinase
  • Morphealike basal cell carcinoma
  • Stromelysin- 3

Fingerprint

Dive into the research topics of 'Stromelysin-3: A potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma'. Together they form a unique fingerprint.

Cite this